Naturally occurring phenolic acids modulate TPA-induced activation of EGFR, AP-1, and STATs in mouse epidermis

Nutrition and Cancer

Volumn 66, Issue 2, 2014, Pages 308-314

  Cichocki, Michał ^a   Dałek, Miłosz ^a   Szamałek, Mateusz ^a   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROGENIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; MYCOPHENOLIC ACID; PHENOLIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTOCATECHUIC ACID; STAT PROTEIN; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; TANNIN; TRANSCRIPTION FACTOR AP 1; TUMOR PROMOTER; TYROSINE; UNCLASSIFIED DRUG; Y 1068; Y 1173;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; EPIDERMIS; EPITHELIUM TUMOR; FEMALE; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SKIN TUMOR; WESTERN BLOTTING;

MUS;

ANIMALS; CARCINOGENS; CHLOROGENIC ACID; EPIDERMIS; FEMALE; HYDROXYBENZOATES; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TANNINS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 84895137773     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.864419     Document Type: Article

References (44)

1. Yates RA, Nanney LB, Gates RE, and King LE Jr: Epidermal growth factor and related growth factors. Int J Dermatol 30, 687-694, 1991.
2. Nicholson RI, Gee JM, and Harper ME: EGFR and cancer prognosis. Eur J Cancer 37, S9-S15, 2001. (Pubitemid 32938124)
3. Yarden Y: The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 37, S3-S8, 2001. (Pubitemid 32938123)
4. Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, et al.: Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 64, 2382-2389, 2004. (Pubitemid 38523890)
5. Di Giovanni J: Multistage carcinogenesis in mouse skin. Pharmacol Ther 54, 63-128, 1992.
6. Yuspa SH: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res 54, 1178-1189, 1994. (Pubitemid 24108054)
7. Abel EL, Angel JM, Kiguchi K, and Di Giovanni J: Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 4, 1350-1362, 2009.
8. Zhou H, Lin A, Gu Z, Chen S, Park NH, et al.: 12-O-tetradecanoylphorbol- 13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPAinducible JNK activity. J Biol Chem 275, 22868-22875, 2000. (Pubitemid 30646172)
9. Cichocki M, Szamałek M, Dałek M, and Baer-Dubowska W: Correlation between EGFR Y1068 tyrosine phosphorylation and AP-1 activation by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin. Environ Toxicol Pharmacol 33, 92-97, 2012.
10. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, et al.:Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7, 575-589, 2005. (Pubitemid 40799250)
11. Quesnelle KM, Boehm AL, and Grandis JR: STAT-mediated EGFR signaling in cancer. J Cell Biochem 102, 311-319, 2007. (Pubitemid 47519405)
12. Mukhtar H, Das M, Khan WM, Wang ZY, Bik DP, et al.: Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimetthylbenz(a)anthracene-, benzo(a)pyrene-, 3- methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48, 2361-2365, 1988.
13. Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, et al.: Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J Cell Biochem Suppl 27, 35-41, 1997. (Pubitemid 28222117)
14. Nepka C, Asprodini E, and Kouretas D: Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. Eur J Drug Metab Pharmacokinet 24, 183-189, 1999. (Pubitemid 29435620)
15. Weng CJ and Yen GC: Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38, 76-87, 2012.
16. Baer-Dubowska W, Gnojkowski J, and Fenrych W: Effects of tannic acid on benzo[a]pyrene-DNA adducts formation in mouse epidermis: comparison with synthetic gallic acid esters. Nutr Cancer 29, 42-47, 1997. (Pubitemid 27508123)
17. Ignatowicz E, Balana B, Vulimiri SV, Szaefer H, and Baer-Dubowska W: The effect of plant phenolics on the formation of 7,12-dimethylbenz[a] anthracene-DNA adducts and TPA-stimulated polymorphonuclear neutrophils chemiluminescence in vitro. Toxicology 189, 199-209, 2003. (Pubitemid 36773856)
18. Szaefer H, Cichocki M, Brauze D, and Baer-Dubowska W: Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis. Nutr Cancer 48, 70-77, 2004. (Pubitemid 38823548)
19. Cichocki M, Blumczyńska J, and Baer-Dubowska W: Naturally occurring phenolic acids inhibit 12-O-tetradecanoylphorbol-13-acetate induced NFkappa B, iNOS and COX-2 activation in mouse epidermis. Toxicology 268, 118-124, 2010.
20. Szaefer H, Kaczmarek J, Rybczyńska M, and Baer-Dubowska W: The effect of plant phenols on the expression and activity of phorbol ester-induced PKC in mouse epidermis. Toxicology 230, 1-10, 2007. (Pubitemid 46073325)
21. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, et al.: Development of a sensitive multi-well colorimetric assay for active NFkappa B. Nucleic Acids Res 29, E21, 2001.
22. Perchellet JP, Gali HU, Perchellet EM, Klish DS, and Armbrust AD: Antitumour-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin. Basic Life Sci 59, 783-801, 1992.
23. Tseng TH, Hsu JD, Lo MH, Chu CY, Chou FP, et al.: Inhibitory effect of Hibiscus protocatechuic acid on tumour promotion in mouse skin. Cancer Lett 126, 199-207, 1998.
24. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, et al.: Inhibition of activator protein-1, NF-kappa B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem280, 27888-27895, 2005. (Pubitemid 41076906)
25. Abe M, Kuroda Y, Hirose M, Watanabe Y, Nakano M, et al.: Inhibition of autophosphorylation of epidermal growth factor receptor by small peptides in vitro. Br J Pharmacol 147, 402-411, 2006. (Pubitemid 43292283)
26. Weyergang A, Selbo PK, and Berg K: Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor. Biochem Pharmacol 74, 226-235, 2007. (Pubitemid 46890824)
27. Kundu JK, Shin YK, and Surh YJ: Resveratrol modulates phorbol esterinduced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol 72, 1506-1515, 2006. (Pubitemid 44666749)
28. Hibi M, Lin A, Smeal T, Minden A, and Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7, 2135-2148, 1993. (Pubitemid 23336140)
29. Nakamura Y, Torikai K, Ohto Y, Murakami A, Tanaka T, et al.: A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase. Carcinogenesis 21, 1899-1907, 2000.
30. Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, et al.:Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res 54, 5273-5279, 1994. (Pubitemid 24336013)
31. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, et al.: Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 272, 24113-24116, 1997. (Pubitemid 27418602)
32. Lee KW, Kim MS, Kang NJ, Kim DH, Surh YJ, et al.: H-Ras selectively up-regulates MMP-9 and COX-2 through activation of ERK1/2 and NF-kappaB: an implication for invasive phenotype in rat liver epithelial cells. Int J Cancer 119, 1767-1775, 2006. (Pubitemid 44356832)
33. Khan N, Afaq F, Saleem M, Ahmad N, and Mukhtar H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66, 2500-2505, 2006.
34. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, et al.: Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 290, 249-255, 2002. (Pubitemid 34694491)
35. Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, et al.: Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51, 379-385, 2002.
36. Xia L, Wang L, Chung AS, Ivanov SS, Ling MY, et al.: Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277, 30716-30723, 2002. (Pubitemid 34970768)
37. Andl CD, Mizushima T, Oyama K, Bowser M, Nakagawa H, et al.: EGFRinduced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 287, G1227-G1237, 2004. (Pubitemid 39551854)
38. Kannangai R, Sahin F, and Torbenson MS: EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod Pathol 19, 1456-1461, 2006. (Pubitemid 44624164)
39. Kim JH, Lee SC, Ro J, Kang HS, Kim HS, et al.: Jnk signaling pathwaymediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines. Biochem Pharmacol 79, 373-380, 2010.
40. Chen F: JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 72, 379-386, 2012.
41. Lim CP and Cao X: Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem 274, 31055-31061, 1999.
42. Shirakawa T, Kawazoe Y, Tsujikawa T, Jung D, Sato S, et al.: Deactivation of STAT6 through serine 707 phosphorylation by JNK. J Biol Chem 286, 4003-4010, 2011.
43. Rodríguez-Fragoso L, Melendez K, Hudson LG, Lauer FT, and Burchiel SW: EGF-receptor phosphorylation and downstream signaling are activated by benzo[a]pyrene 3,6-quinone and benzo[a]pyrene 1,6-quinone in human mammary epithelial cells. Toxicol Appl Pharmacol 235, 321-328, 2009.
44. Kataoka K, Kim DJ, Carbajal S, Clifford JL, and DiGiovanni J: Stagespecific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumourigenesis. Carcinogenesis 29, 1108-1114, 2008. (Pubitemid 351958688)